home / stock / vygr / vygr quote
Last: | $7.59 |
---|---|
Change Percent: | 0.51% |
Open: | $7.82 |
Close: | $7.59 |
High: | $7.8298 |
Low: | $7.55 |
Volume: | 358,920 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$7.59 | $7.82 | $7.59 | $7.8298 | $7.55 | 358,920 | 07-02-2024 |
$7.86 | $7.87 | $7.86 | $8.0799 | $7.8 | 282,362 | 07-01-2024 |
$7.91 | $7.9 | $7.91 | $7.96 | $7.75 | 2,990,784 | 06-28-2024 |
$7.86 | $7.85 | $7.86 | $7.94 | $7.74 | 269,794 | 06-27-2024 |
$7.8 | $7.81 | $7.8 | $7.87 | $7.6 | 390,852 | 06-26-2024 |
$7.82 | $8.01 | $7.82 | $8.095 | $7.82 | 246,374 | 06-25-2024 |
$8.055 | $8.14 | $8.055 | $8.23 | $8.02 | 400,979 | 06-24-2024 |
$8.09 | $7.91 | $8.09 | $8.18 | $7.81 | 915,402 | 06-21-2024 |
$7.79 | $8.1 | $7.79 | $8.15 | $7.72 | 510,228 | 06-20-2024 |
$8.16 | $8.3 | $8.16 | $8.33 | $8.11 | 331,405 | 06-19-2024 |
$8.16 | $8.3 | $8.16 | $8.33 | $8.11 | 331,405 | 06-18-2024 |
$8.26 | $8.45 | $8.26 | $8.45 | $8.2 | 345,120 | 06-17-2024 |
$8.51 | $8.65 | $8.51 | $8.77 | $8.45 | 378,146 | 06-14-2024 |
$8.8 | $8.64 | $8.8 | $8.815 | $8.5931 | 208,010 | 06-13-2024 |
$8.67 | $8.78 | $8.67 | $9.06 | $8.585 | 370,167 | 06-12-2024 |
$8.67 | $8.63 | $8.67 | $8.765 | $8.5 | 284,204 | 06-11-2024 |
$8.77 | $8.33 | $8.77 | $8.78 | $8.2 | 461,877 | 06-10-2024 |
$8.42 | $8.39 | $8.42 | $8.6 | $8.39 | 236,345 | 06-07-2024 |
$8.48 | $8.66 | $8.48 | $8.68 | $8.41 | 336,350 | 06-06-2024 |
$8.7 | $8.58 | $8.7 | $8.73 | $8.45 | 327,979 | 06-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
Voyager Therapeutics Inc. Company Name:
VYGR Stock Symbol:
NASDAQ Market:
Voyager Therapeutics Inc. Website:
LEXINGTON, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that the company will participate in fireside chats at the TD Cowen Genetic Medicines & RNA Summit on June 20, ...
LEXINGTON, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced the appointment of Nathan Jorgensen, Ph.D., MBA, as Chief Financial Officer (CFO), effective July 8, 2024. Jorgense...
LEXINGTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that the first participants were dosed in a Phase 1a single ascending dose (SAD) trial of VY-TAU01, an investigation...